Clinical Trial Update: Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating allogeneic mesenchymal stromal cells in elderly patients with femoral neck fracture has been withdrawn (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoral Neck Fracture
• Hip Fracture

Drugs mentioned

• Allogeneic Mesenchymal Stromal Cells (mesenchymal stromal cells)

Snippet

Sponsor: Banc de Sang i Teixits | Conditions: Femoral Neck Fracture | Phase 1, Phase 2 | Status: WITHDRAWN